Dow Up 1.13% Nasdaq Up 1.41%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
55.27 Up 0.90(1.66%) 4:00PM EDT
|After Hours : 55.28 Up 0.01 (0.01%) 4:49PM EDT
Prev Close:54.37
Open:55.60
Bid:52.66 x 100
Ask:59.26 x 100
1y Target Est:90.70
Beta:1.56
Next Earnings Date:N/A
Day's Range:54.80 - 57.32
52wk Range:41.99 - 80.42
Volume:359,983
Avg Vol (3m):440,550
Market Cap:1.13B
P/E (ttm):167.48
EPS (ttm):0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDUp 1.66%1.13B
LLYDown 0.70%71.26B
MRKUp 1.10%167.14B
RHHBYDown 1.00%250.12B

Key Statistics

Forward P/E (1 yr):22.84
P/S (ttm):19.73
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.52
Quarterly EPS Est (Dec-14) :0.62
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback